David Alan Goodkin
Corporate Officer/Principal at Goodkin Biopharma Consulting LLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mike Zahigian | M | - | 23 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Marc M. P. de Garidel | M | 66 | 15 years | |
| Madhavan Balachandran | M | 73 | 20 years | |
| Paul Clark | M | 76 |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | 8 years |
| Kathryn Falberg | F | 63 | 6 years | |
| Kevin Sharer | M | 76 | 20 years | |
| William P. Sheridan | M | 69 | 5 years | |
| James Daly | M | 63 | 9 years | |
| John Moriarty | M | 56 | 6 years | |
| Martin Simonetti | M | 66 | 7 years | |
| Judith C. Pelham | F | 78 | 22 years | |
| George Morrow | M | 72 | 10 years | |
| Frans Gustaf Wuite | M | 64 | - | |
| John Smither | M | 71 | 6 years | |
| J. Reason | M | 83 | 12 years | |
| Gary L. Wilcox | M | 77 |
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | 14 years |
| William D. Welch | M | - |
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | 10 years |
| Thomas Zindrick | M | 65 | 8 years | |
| Sean E. Harper | M | 61 | 16 years | |
| Frank J. Biondi | M | 79 | 15 years | |
| David Baltimore | M | 86 | 21 years | |
| Susan Lundeen Smuck | F | 57 | 12 years | |
| Jerry D. Choate | M | 86 | - | |
| Rachel Lenington | F | 51 | 10 years | |
| Patricia A. Turney | F | 57 | 23 years | |
| Frederick Gluck | M | 88 | 13 years | |
| Brian M. McNamee | M | 67 | - | |
| Henry R. Appelbaum | M | - | 9 years | |
| Alex M. DePaoli | M | - | - | |
| Anand Varadan | M | 57 | 16 years | |
| Warren Wayne Myers | M | 62 | 10 years | |
| Randal A. Hassler | M | 66 | 12 years | |
| Greg Gauthier | M | - |
Venturi Ventures, Inc.
 Venturi Ventures, Inc. Medical SpecialtiesHealth Technology Venturi Ventures, Inc. engages in the development and marketing of its advanced verification of integration dose technology. The company was founded on December 3, 1980 and is headquartered in North Vancouver, Canada. | 3 years |
| William Richards | M | 63 | 23 years | |
| Xue Ming Qian | M | 57 | 13 years | |
| Sesha Neervannan | M | 56 | 8 years | |
| Eric Grinstead | M | 66 | 7 years | |
| Wen Chen | M | 56 | - | |
| Andrew Gengos | M | 59 | 8 years | |
| Kevin L. Stark | M | - | 15 years | |
| Robert M. Brenner | M | 56 | 9 years | |
| Daniel Flynn | M | 70 | - | |
| Michael A. Grabow | M | - | 13 years | |
| Gilbert M. Rishton | M | - | 9 years | |
| David Green | M | - | 11 years | |
| Alan Barge | M | - | 8 years | |
| Luis Borges | M | 62 | 12 years | |
| Ann Miller | M | 66 | 5 years | |
| Gary Palmer | M | - | 5 years | |
| Mark Daniels | M | 61 | 21 years | |
| Gordon Ng | M | - | 9 years | |
| Aron M. Knickerbocker | M | 54 | 4 years | |
| David Hovland | M | - | 8 years | |
| Sandra Milligan | M | 60 | 10 years | |
| Urte Gayko | M | 53 | 9 years | |
| Laura Hamill | F | 60 | 18 years | |
| David Lacey | M | 71 | 17 years | |
| Bradley J. Maroni | M | 71 | 6 years | |
| Juan Jaen | M | 66 | 10 years | |
| Doug Farrar | M | 59 | 7 years | |
| Kevin Koch | M | 63 | 3 years | |
| Daniel Vapnek | M | 85 | 15 years | |
| Robert John Herbold | M | 81 |
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | - |
| Richard Nanula | M | 63 | 6 years | |
| Stephen Blackwood | M | 61 | 7 years | |
| Maureen P. Brogan | F | 62 | 3 years | |
| Timothy McNamara | M | 67 | 3 years | |
| Larry Alan May | M | 74 | 15 years | |
| Wen-Tse Tseng | M | - | 5 years | |
| John F. Weidenbruch | M | 63 | 10 years | |
| Carol Gallagher | M | 59 | 8 years | |
| Robert S. Attiyeh | M | 90 | 4 years | |
| Charles R. Bradley | M | - | 5 years | |
| Beth Seidenberg | M | 67 | 3 years | |
| Roger Perlmutter | M | 71 | 11 years | |
| Fabrizio Bonanni | M | 78 | 14 years | |
| John G. Adair | M | - | 6 years | |
| Paul Geyer | M | 61 |
Venturi Ventures, Inc.
Venturi Ventures, Inc. Medical SpecialtiesHealth Technology Venturi Ventures, Inc. engages in the development and marketing of its advanced verification of integration dose technology. The company was founded on December 3, 1980 and is headquartered in North Vancouver, Canada. | 6 years |
| Kevin B. Young | M | 66 | 3 years | |
| Lisa Guttman | F | - | 7 years | |
| Kathleen M. Wiltsey | F | 68 | 14 years | |
| Nacer E. Dean Abrouk | M | - | 4 years | |
| Gregory Stea | M | 66 | 9 years | |
| Carl LeBel | M | 65 | 10 years | |
| Robin D. Campbell | M | 69 | 13 years | |
| Lisa A. Evrén | F | - | 5 years | |
| Jonathan Jackson | M | 57 |
Venturi Ventures, Inc.
Venturi Ventures, Inc. Medical SpecialtiesHealth Technology Venturi Ventures, Inc. engages in the development and marketing of its advanced verification of integration dose technology. The company was founded on December 3, 1980 and is headquartered in North Vancouver, Canada. | 2 years |
| Daniel J. Burge | M | 62 | 1 years | |
| Zeid Mohamedali | M | - |
Venturi Ventures, Inc.
Venturi Ventures, Inc. Medical SpecialtiesHealth Technology Venturi Ventures, Inc. engages in the development and marketing of its advanced verification of integration dose technology. The company was founded on December 3, 1980 and is headquartered in North Vancouver, Canada. | 4 years |
| T. Tyler Ellison | M | - | 1 years | |
| Richard Yeh | M | 56 | - | |
| Bradford Zakes | M | 57 |
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | 4 years |
| Denny Lanfear | M | 68 | 13 years | |
| Henry Wu | M | - | - | |
| Pirow Bekker | M | 63 | 8 years | |
| Martha E. Vincent | M | - | 9 years | |
| Philip C. Ranker | M | 64 |
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | 3 years |
| David Hallal | M | 56 | 10 years | |
| Kevin Leong | M | - |
Venturi Ventures, Inc.
Venturi Ventures, Inc. Medical SpecialtiesHealth Technology Venturi Ventures, Inc. engages in the development and marketing of its advanced verification of integration dose technology. The company was founded on December 3, 1980 and is headquartered in North Vancouver, Canada. | 2 years |
| Kimberly Ann Davis | F | 56 | 11 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 95 | 95.00% |
| Canada | 5 | 5.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David Alan Goodkin
- Personal Network
